Position in ANNX
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$2,253,166
-$55,340 QoQ
Shares Held
394,600
-5.3% QoQ
Ownership
0.193%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#64
of 216 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ANNX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026MUTUAL OF AMERICA CAPITAL MANAGEMENT LLC holds $184,059,662 across 45 Biotechnology names. ANNX ranks #31 (1.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
191,432 | $15,603,622 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
26,109 | $12,969,123 | |
| 3 | KRYS |
Krystal Biotech, Inc.
|
31,998 | $11,892,696 | |
| 4 | CYTK |
Cytokinetics Inc
|
121,652 | $10,363,533 | |
| 5 | AXSM |
Axsome Therapeutics, Inc.
|
40,364 | $9,879,896 | |
| 6 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
12,418 | $6,667,845 | |
| 7 | XENE |
Xenon Pharmaceuticals Inc.
|
109,603 | $6,615,637 | |
| 8 | VCEL |
Vericel Corp
|
145,445 | $6,470,848 |
All Filings in ANNX
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,253,166 | 394,600 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $2,308,506 | 416,698 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $3,223,030 | 642,038 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $3,254,142 | 1,066,932 | Shares | Sole | 2025-10-31 | |
| 2025-06-30 | $2,589,506 | 1,078,961 | Shares | Sole | 2025-07-29 | |
| 2025-03-31 | $1,989,218 | 1,030,683 | Shares | Sole | 2025-05-09 | |
| 2024-12-31 | $5,282,258 | 1,029,680 | Shares | Sole | 2025-02-05 | |
| 2024-09-30 | $3,902,783 | 659,254 | Shares | Sole | 2024-11-06 | |
| 2024-06-30 | $3,133,907 | 639,573 | Shares | Sole | 2024-08-09 | |
| No filing history on record for this holder in this stock. | ||||||